2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]

When Venture Capital is Patient Capital: Seed funding as a source of patient capital for high-growth companies

This annual report analyzes venture capital activity in 2023–2024, covering deal structures, valuation dynamics, exit conditions, and evolving investor protections. It highlights tighter financing conditions, increased use of structured terms, and longer exit timelines as the market normalizes after the boom years.

Why is relevant?

A practitioner-grade snapshot of how VC terms, governance, and exits are evolving in the current cycle. Especially relevant for founders and investors negotiating rounds in a more disciplined, lawyer-driven market.
When Venture Capital is Patient Capital: Seed funding as a source of patient capital for high-growth companies, investment firm website screenshot
Author
WilmerHale Venture Capital Practice
Publication date
January 1st, 2024
Difficulty
Intermediate
Keywords
  • Venture capital trends
  • deal terms
  • exits
  • regulatory environment
  • fundraising
Last update